Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
Thymosin beta4 promotes oligodendrogenesis in the demyelinating central nervous system.
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Brain activity changes in cognitive networks in relapsing-remitting multiple sclerosis - insights from a longitudinal FMRI study.
Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.
Pathologic laughing as a presenting feature in a patient with neuromyelitis optica.
n-3 PUFAs Reduce T-Helper 17 Differentiation by Decreasing Responsiveness to Interleukin-6 in Isolated Splenic Mouse CD4+ T Cells.
A randomized, controlled trial of fingolimod (FTY720) in Japanese patients with multiple sclerosis.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Clinical and neuroimaging correlation of movement disorders in multiple sclerosis: case series and review of the literature.
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1.
A role for human brain pericytes in neuroinflammation.
A rare case of hyponatremia from a hypothalamic lesion in a patient with multiple sclerosis.
Neurofascin antibodies in inflammatory neuropathy: How many needles make a haystack?
Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.
Brain disorders where resources are scarce: The unfinished agenda.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Subcutaneous IgG in neurologic diseases.
The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.
Promoting remyelination: utilizing a viral model of demyelination to assess cell-based therapies.
Gene profile analysis implicates Klotho as an important contributor to aging changes in brain white matter of the rhesus monkey.
Facial and Bodily Emotion Recognition in Multiple Sclerosis: The Role of Alexithymia and Other Characteristics of the Disease.
Diazepam Inhibits Proliferation of Lymph Node Cells Isolated from Rats with Experimental Autoimmune Encephalomyelitis.
[Optic neuritis after influenza vaccination in a patient after stem cell transplantation].
Pages
« first
‹ previous
…
397
398
399
400
401
402
403
404
405
…
next ›
last »